biote Corp. (BTMD): Total Liabilities

Annual figures by period end, from SEC filings.

$158.01M
As of 2025-12-31
$159.89M
As of 2026-06-30
-2.4%
3-year compound annual growth
n/m
5-year compound annual growth
$224.57M2020-12-31: $122.5K2021-12-31: $50.20M2022-12-31: $169.92M2023-12-31: $191.84M2024-12-31: $224.57M2025-12-31: $158.01M$158.01M
2020-12-31 Total Liabilities (USD) 2025-12-31
Period endedTotal LiabilitiesChange YoYSource filing
2025-12-31$158.01M-29.6%2026-03-13, Balance as of period end
2024-12-31$224.57M+17.1%2026-03-13, Balance as of period end
2023-12-31$191.84M+12.9%2025-03-14, Balance as of period end
2022-12-31$169.92M+238.5%2024-03-15, Balance as of period end
2021-12-31$50.20Mn/m2023-03-29, Balance as of period end
2020-12-31$122.5Kn/a2022-04-07, Balance as of period end

Total Liabilities at similar companies

Companies with the same SEC industry code (Medicinal Chemicals & Botanical Products), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedTotal LiabilitiesChange YoY
biote Corp. (BTMD)2025-12-31$158.01M-29.6%
Glass House Brands Inc. (GLAS)2025-12-31$143.96M-1.7%
Marimed Inc. (MRMD)2025-12-31$137.83M+6.5%
Cronos Group Inc. (CRON)2025-12-31$54.18M-2.1%
Natural Alternatives International Inc (NAII)2026-06-30$76.49M-8.4%
Jushi Holdings Inc. (JUSH)2025-12-31$537.69M+9.6%
Niagen Bioscience, Inc. (NAGE)2025-12-31$29.87M+34.7%
Mannatech Inc (MTEX)2025-12-31$35.22M+28.3%
Fitlife Brands, Inc. (FTLF)2025-12-31$62.68M+179.8%

Compare BTMD, GLAS, MRMD, CRON side by side · Screen every company in Medicinal Chemicals & Botanical Products ↗